EGFR and breast cancer: Peptide 1 (or GE11) is a dodecapeptide that binds specifically to the epidermal growth factor receptor (EGFR or ErbB1) overexpressed in a number of tumors of epithelial origin including breast cancer, and is being used as a cancer cell-targeting peptide (Genta et al., 2017).